About Sniper Sniper
Lead the future of digital PCR with VibroJet technology.
Our Mission
To provide accessible and precise diagnostic solutions for everyone.
We believe that everyone deserves high-quality and reliable diagnostic services. Through continuous technological innovation and industrialization, Sniper Technology is committed tomaking advanced digital PCR detection more accessible and integrated into daily healthcare.
Making An Impact
We are driven to make a meaningfulimpact for our customers and ourcommunity.
VibroJet®
Patents
Technical lnnovation
3
Branch Offices
Full-link self-research
and self-production
and self-production
25
Average Age
A Younger Team
Our Vision
Empowering global health with technology
— making high-quality diagnostics
universally available.
— making high-quality diagnostics
universally available.
Our Culture
Attitude over experience
Evidence-based and open debate
Rational analysis, fast decision-making
Decisive execution, timely feedback
Evidence-based and open debate
Rational analysis, fast decision-making
Decisive execution, timely feedback
Core Values
Driven by Purpose
Equity and Sharing
Dare to Lead
Sustainable Innovation
Equity and Sharing
Dare to Lead
Sustainable Innovation
About Milestones
To become a globally trusted technical standard-setter and solution provider in the field of molecular diagnostics,
and to build a life science company that can thrive for a hundred years.
2018
Company founded;
initiated R&D of proprietary
"VibroJet-based digital PCR" technology.
initiated R&D of proprietary
"VibroJet-based digital PCR" technology.
VibroJect® V=Q/2f
V: Droplet Volume
Q: Flow Rate
F: Vibration Frequency
2021
Entered clinical testing;
selected into China’s NMPA
innovation green channel.
selected into China’s NMPA
innovation green channel.
2023
Received FDA approval,
becoming the only approved fully
automated digital PCR platform.
becoming the only approved fully
automated digital PCR platform.
2020
Completed digital PCR prototype;
secured angel round financing.
secured angel round financing.
2022
Launched DQ-24, the first fully
automated digital PCR platform.
automated digital PCR platform.
2024
Began international market expansion with partnerships and global reagent co-development.